Treating VISual hallucinations in people with MACular degeneration: a non-invasive stimulation study (VISMAC) at Newcastle University.
We are looking for patients with eye disease with moderate to severe visual impairment who have not experienced visual hallucinations to take part in our research study, VISMAC, at the Campus for Ageing and Vitality (as part of the Institute of Neuroscience).
It is common for people with eye disease to experience visual hallucinations, a condition known as Charles Bonnet Syndrome. These hallucinations are often distressing and can disrupt day-to-day functioning. Currently it is unclear what causes visual hallucinations in people with eye disease and there are no effective treatments.
We are keen to understand more about this condition by using techniques that measure brain activity, such as brain imaging and electroencephalography (EEG). In order to understand more about visual hallucinations and why they occur, it is important that we compare the activity in the brain between people with eye disease who experience visual hallucinations and people who do not. Understanding more about visual hallucinations is an important first step in the development of future treatments for people with Charles Bonnet Syndrome and will help to inform further areas of research.